Turnkey Contract Research Organization Facility Available
In a rare and exciting opportunity, a premier Contract Research Organization (CRO) facility, previously operated by AmplifyBio, is available for sale. This transition comes under the guidance of the U.S. Bankruptcy Court, creating a unique chance for buyers interested in cutting-edge biopharmaceutical research.
A Strategic Location with Key Features
The facility, which spans over 205,000 square feet, includes 65,000 square feet of specialized laboratory space designed for high-complexity research. Among its many features is a 64-room vivarium, complete with a one-way traffic design for streamlined workflows. Additionally, it boasts a fully equipped on-site surgical suite, making it ideal for a variety of regulated research applications.
Equipped for Innovation
This CRO facility is tailored to support the development of pharmaceuticals, biotechnology products, and medical devices. It houses integrated laboratories that offer essential services in toxicology and bioanalytic characterization, facilitating modern therapeutic innovations.
A Legacy of Excellence in Biotechnology
Founded in 2021, AmplifyBio quickly built a reputation as a leader in advanced therapeutic solutions, with a strong backing of over $200 million in funding. The company specialized in groundbreaking technologies such as gene editing, mRNA therapies, and T-cell-based approaches, successfully operating state-of-the-art facilities in multiple locations.
Expert Insights on the Sale
Joel Schneider, senior vice president at Hilco Real Estate, remarked on the exceptional nature of this sale, noting that it offers a complete solution with top-tier laboratory and office space suitable for a myriad of advanced research initiatives. The facility’s available state-of-the-art equipment presents an enticing proposition for CROs and other research organizations looking to expand or establish new operations.
Intellectual Property and Equipment Highlights
Another major allure of this sale is the extensive portfolio of patents held by AmplifyBio. This includes 119 issued and pending patents related to non-viral gene editing, immunotherapy, and innovative cell engineering methods. These assets not only represent significant potential for future research but are also pivotal in areas such as oncology and personalized medicine.
Interested Bidders Should Act Promptly
Potential buyers should be aware that bids for the facility must be submitted by the established deadline. Interested parties are encouraged to review the comprehensive bid procedures provided for this unique sale opportunity. For further information regarding the asset purchase agreement, details can be found online.
Contact Information for Interested Bidders
For those seeking to inquire further or arrange an on-site inspection, Chet Evans at Hilco Real Estate is available for contact at (847) 418-2702. This is a wonderful opportunity for serious bidders to explore all that this facility has to offer.
Conclusion: A Rare Sale
In conclusion, the availability of this CRO facility presents a remarkable chance for investors looking to make a significant impact in the biotech industry. As it comes with not only a sophisticated laboratory but also a wealth of knowledge through its patent portfolio, it invites interested parties to explore what could be a game-changer for their research endeavors.
Frequently Asked Questions
What is being offered for sale?
A fully integrated CRO facility that includes real estate, laboratory equipment, and intellectual property.
Why is the facility for sale?
The sale is part of a bankruptcy process involving the previous owner, AmplifyBio.
What are the features of the CRO facility?
The facility features specialized lab space, a vivarium, and a surgical suite, all designed for high-complexity research.
Who can participate in the bidding process?
Interested bidders are encouraged to review the official bid procedures, which are available online.
How can I get more details about the sale?
For inquiries and additional information, potential buyers should contact Chet Evans at Hilco Real Estate.
